Sources: US News
The Therapeutic Goods Administration grants provisional approval for Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug. 2022-01-20
Bahrain authorizes the emergency use of Pfizer's anti-viral oral drug Paxlovid for adults over the age of 18 years. 2022-01-1
Pfizer says that they plan to develop new vaccines for other viruses following the success of their COVID-19 vaccine candidate. 2021-03-23
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
The European Medicines Agency conditionally approves the vaccine made by Pfizer and BioNTech for use in European Union countries. 2020-12-21
The Ministry of Public Health approves the authorization of the Pfizer-BioNTech vaccine for emergency use in Qatar. 2020-12-20
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine. 2020-12-8
The Indian government announces that the country will speed up their reviews of vaccines developed by Pfizer and AstraZeneca. 2020-12-7
Pfizer announces that it has received approval from the Food and Drug Administration for vaccine trials on children at least 12 years old. The trials are expected to begin at the Cincinnati Children's Hospital Medical Center in Ohio. 2020-10-13